Yao Ying, Wang Shuang, Li Dan-Yang, Yu Xiao-Juan, Liu Jia-Yi, Qiu Zhi-Xiang, Zhou Fu-De, Wang Su-Xia
Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, P.R. China.
Renal Division, Department of Medicine, Peking University First Hospital; Renal Pathological Center, Institute of Nephrology, Peking University; Key Laboratory of Renal Diseases, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, P.R. China.
Ren Fail. 2025 Dec;47(1):2499230. doi: 10.1080/0886022X.2025.2499230. Epub 2025 May 19.
This study evaluates the relationship between renal amyloid deposition burden in kidney biopsy and a renal staging system based on proteinuria and estimated glomerular filtration rate (eGFR) in AL amyloidosis.
A total of 248 patients diagnosed renal biopsy were included. The extent of amyloid deposition in glomeruli, blood vessels, and tubulointerstitium were evaluated semiquantitatively. The total amyloid load (TA) was defined by the sum of glomerular, vascular and interstitial deposits.
Patients were categorized into three renal stages: I, II, and III. Findings showed that scores of pathological parameters increased progressive with advancing renal stage. The median TA values were 6 (IQR 3-8) in Stage I, 7 (IQR 5-8) in Stage II, and 8 (IQR 7-11) in Stage III ( < 0.001). Baseline eGFR was inversely correlated with TA ( = -0.363, < 0.001), while proteinuria showed no significant association. Cox regression analysis identified eGFR <50 mL/min/1.73 m as an independent risk factor for renal survival (HR, 6.519; 95% CI, 3.110-13.665; < 0.001), whereas proteinuria did not show such an effect.
These findings suggest that in the renal staging system, eGFR - but not proteinuria - is significantly associated with amyloid deposition and independently affects renal survival.
本研究评估肾活检中肾脏淀粉样蛋白沉积负荷与基于蛋白尿和估计肾小球滤过率(eGFR)的AL淀粉样变性肾脏分期系统之间的关系。
共纳入248例经肾活检确诊的患者。对肾小球、血管和肾小管间质中淀粉样蛋白沉积的程度进行半定量评估。总淀粉样蛋白负荷(TA)由肾小球、血管和间质沉积物的总和定义。
患者被分为三个肾脏阶段:I期、II期和III期。结果显示,病理参数评分随着肾脏阶段的进展而逐渐增加。I期的TA中位数为6(四分位间距3-8),II期为7(四分位间距5-8),III期为8(四分位间距7-11)(<0.001)。基线eGFR与TA呈负相关(=-0.363,<0.001),而蛋白尿无显著相关性。Cox回归分析确定eGFR<50 mL/min/1.73 m²为肾脏生存的独立危险因素(HR,6.519;95%CI,3.110-13.665;<0.001),而蛋白尿未显示出这种作用。
这些发现表明,在肾脏分期系统中,eGFR而非蛋白尿与淀粉样蛋白沉积显著相关,并独立影响肾脏生存。